Trademark Search / ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
○ Dead · AbandonedU.S. federal trademark · Serial No. 85525635
Mark
ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
Filing Date
January 26, 2012
Goods & Services
Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use for pharmaceutical research and development
Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL" or anything like it, before you file.
Run a free trademark search →Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.